Received: 28 September 2018
Accepted: 22 January 2019
First Online: 5 February 2019
Ethics approval and consent to participate
: Not applicable.
: E.S. is an employee of GSK. M.G. has performed consultancy for Sanofi and receives research funding from AstraZeneca. This work was funded by Open Targets which is private-public initiative. All other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.